Overview
Also known as:
Clinical phenotype terms— hover any for plain English:
FDA & Trial Timeline
6 eventsSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Antonio Bellasi
Kyowa Kirin Korea Co., Ltd.
Medical University of Gdansk
Maimónides Biomedical Research Institute of Córdoba
University of Maryland, Baltimore — PHASE1
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Autosomal dominant hypophosphatemic rickets.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal dominant hypophosphatemic rickets at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal dominant hypophosphatemic rickets.
Community
No community posts yet. Be the first to share your experience with Autosomal dominant hypophosphatemic rickets.
Start the conversation →Latest news about Autosomal dominant hypophosphatemic rickets
Disease timeline:
New recruiting trial: Fibroblast Growth Factor 23 and Risk of Cardiac Arrhythmias in Hemodialysis Patients
A new clinical trial is recruiting patients for Autosomal dominant hypophosphatemic rickets
New recruiting trial: FGF23 and Cardiovascular Damage in Anemia With an Without Chronic Kidney Disease.
A new clinical trial is recruiting patients for Autosomal dominant hypophosphatemic rickets
New recruiting trial: Vitamin D in Dialysis Patients - Diagnostic and Therapeutic Management
A new clinical trial is recruiting patients for Autosomal dominant hypophosphatemic rickets
New recruiting trial: Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients
A new clinical trial is recruiting patients for Autosomal dominant hypophosphatemic rickets
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Autosomal dominant hypophosphatemic rickets
Which specialists treat Autosomal dominant hypophosphatemic rickets?
3 specialists and care centers treating Autosomal dominant hypophosphatemic rickets are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.